Diabetes Technology

Semaglutide and Cardiovascular Outcomes - Dr. Michael Bruce Orwin on how Semaglutide reduces cardiovascular risks in non-diabetic obese patients. 💉

Explore whether diabetic retinopathy is reversible and learn the key interventions for eye health with our expert insights. 👁️